Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy
Journal of Controlled Release · 2023-02 · 354 · 196-206
DOI: 10.1016/j.jconrel.2023.01.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-02. Verfasst von Yan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, United States. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Reactive oxygen species (ROS) generation to induce cell death is an effective strategy for cancer therapy. In particular, chemodynamic therapy (CDT), using Fenton-type reactions to generate highly cytotoxic hydroxyl radical (•OH), is a promising treatment modality. However, the therapeutic efficacy of ROS-based cancer treatment is still limited by some critical challenges, such as overexpression of enzymatic and non-enzymatic antioxidants by tumor cells, as well as the low tumor targeting efficiency of therapeutic agents. To address those problems, biomimetic CuZn protoporphyrin IX nanoscale coordination polymers have been developed, which significantly amplify oxidative stress against tumors by simultaneously inhibiting enzymatic and non-enzymatic antioxidants and initiating the CDT. In this design, cancer cell membrane camouflaged nanoparticle exhibits an excellent homotypic targeting effect. After being endocytosed into tumor cells, the nanoparticles induce depletion of the main non-enzymatic antioxidant glutathione (GSH) by undergoing a redox reaction with GSH. Afterward, the redox reaction generated cuprous ion (Cu+) works as a CDT agent for •OH generation. Furthermore, the released Zn protoporphyrin IX strongly inhibits the activity of the typical enzymatic antioxidant heme oxygenase-1. This tetra-modal synergistic strategy endows the biomimetic nanoparticles with great capability for anticancer therapy, which has been demonstrated in both in vitro and in vivo studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, United States.
- D2M Biotherapeutics, Natick, MA 01760, United States.
- Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, United States; Captis Diagnostics Inc, Pittsburgh, PA 15213, United States.
- Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, United States; Electrical & Computer Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, United States. Electronic address: siyangz@an…
Förderung
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Zhang, Y., Wang, F., Shi, L., Lu, M., Lee, K. J., Ditty, M. M., Xing, Y., He, H. Z., Ren, X., & Zheng, S. Y. (2023). Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy. Journal of Controlled Release, 354, 196-206. https://doi.org/10.1016/j.jconrel.2023.01.004
Vancouver
Zhang Y, Wang F, Shi L, Lu M, Lee KJ, Ditty MM, et al. Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy. Journal of Controlled Release. 2023;354:196-206. doi:10.1016/j.jconrel.2023.01.004
BibTeX
@article{Zhang2023,
author = {Zhang, Yan and Wang, Faming and Shi, Lai and Lu, Mengrou and Lee, Keng-Jung and Ditty, Mackenzie Maurer and Xing, Yunhui and He, Hong-Zhang and Ren, Xi and Zheng, Si-Yang},
title = {Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy},
journal = {Journal of Controlled Release},
year = {2023},
volume = {354},
pages = {196--206},
doi = {10.1016/j.jconrel.2023.01.004}
}
EUVIMED